Neurology. 1975 Feb;25(2):135-40.

Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.

Abstract

Three patients with postanoxic intention myoclonus, two patients with intention tremor, and one patient with cerebral palsy were administered L-5-hydroxytryptophan (L-5HTP), the precursor of serotonin, in combination with MK 486, a peripheral amino acid decarboxylase inhibitor. L-5HTP combined with MK 486 were potent long-term therapeutic agents for postanoxic intention myoclonus, but had no effect on intention tremor or cerebral palsy. These drugs were well-tolerated by the patients, and more effective than any other known therapy for intention myoclonus. Cerebrospinal fluid concentration of 5-hydroxyindoleacetic acid, the main catabolite of serotonin, appeared low in two patients with intention myoclonus and increased markedly during drug therapy. Postanoxic intention myoclonus may be causally related to a deficiency of brain serotonin.

PMID:: 1078720; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Ovid Technologies, Inc.

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa. [N Engl J Med. 1977]
Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa.
Van Woert MH, Rosenbaum D, Howieson J, Bowers MB Jr. N Engl J Med. 1977 Jan 13; 296(2):70-5.
Serotonin and myoclonus. [Monogr Neural Sci. 1976]
Serotonin and myoclonus.
Van Woert MH, Jutkowitz R, Rosenbaum D, Bowers MB Jr. Monogr Neural Sci. 1976; 3:71-80.
Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor. [Acta Neurol Scand. 1978]
Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor.
Magnussen I, Dupont E, Engbaek F, de Fine Olivarius B. Acta Neurol Scand. 1978 Apr; 57(4):289-94.
Review Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists. [Arch Neurol. 1994]
Review Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists.
Pranzatelli MR. Arch Neurol. 1994 Jun; 51(6):605-17.
Review Central serotonin deficiency--a factor which increases depression vulnerability? [Acta Psychiatr Scand Suppl. 1980]
Review Central serotonin deficiency--a factor which increases depression vulnerability?
van Praag HM, de Haan S. Acta Psychiatr Scand Suppl. 1980; 280:89-96.

See reviews... See all...

Cited by 6 PubMed Central articles

Observations on chloralose-induced myoclonus in guinea-pigs. [Br J Pharmacol. 1980]
Observations on chloralose-induced myoclonus in guinea-pigs.
Chadwick D, Hallett M, Jenner P, Marsden CD. Br J Pharmacol. 1980 Jul; 69(3):535-40.
Dopamine agonists suppress visual-cortical reflex myoclonus. [J Neurol Neurosurg Psychiatry....]
Dopamine agonists suppress visual-cortical reflex myoclonus.
Obeso JA, Artieda J, Tuñón T, Luquin MR, Martínez Lage JM. J Neurol Neurosurg Psychiatry. 1985 Dec; 48(12):1277-83.
Central serotonergic stimulation of aldosterone secretion. [J Clin Invest. 1985]
Central serotonergic stimulation of aldosterone secretion.
Shenker Y, Gross MD, Grekin RJ. J Clin Invest. 1985 Oct; 76(4):1485-90.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decar...
Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.
Neurology. 1975 Feb ;25(2):135-40.

PubMed
Quality of life in patients with axonal polyneuropathy.
Quality of life in patients with axonal polyneuropathy.
J Neurol. 2000 Mar ;247(3):195-9.

PubMed
HIV-1 genome nuclear import is mediated by a central DNA flap.
HIV-1 genome nuclear import is mediated by a central DNA flap.
Cell. 2000 Apr 14 ;101(2):173-85.

PubMed
Mighty mice.
Mighty mice.
Nature. 2000 Apr 20 ;404(6780):815.

PubMed
Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.
Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.
Cancer Res. 2000 Apr 15 ;60(8):2190-6.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.

Abstract

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 6 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information